Dr Reddy's Laboratories Q4 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01031
- Sector: Biotechnology & Drugs
BSE
1,198.95
-6.05 (-0.50%)
-6.05 (-0.50%)Volume95.45 K
Updated: Wed 12 Aug, 2026 | 15:51:48
NSE
1,200-5.00 (-0.41%)
-5.00 (-0.41%)Volume2.37 M
Updated: Wed 12 Aug, 2026 | 15:14:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Dr Reddy's Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 7,721.00 | 7,386.90 | 4.52% | 5,648.70 | 11.18% |
| Depreciation/ Amortization | 557.10 | 521.00 | 6.93% | 367.70 | 22.52% |
| Operating Income | -,174.60 | 1,366.50 | 0.00% | 1,465.10 | 0.00% |
| Net Income | 220.90 | 1,209.90 | -81.74% | 1,309.80 | -86.14% |
| Other Operating Expenses Total | 2,246.90 | 2,155.10 | 4.26% | - | 3.90% |
| Net Income Before Taxes | 199.70 | 1,543.20 | -87.06% | 1,605.20 | -90.04% |
| Total Revenue | 7,546.40 | 8,753.40 | -13.79% | 7,113.80 | -11.51% |
| Selling/ General/ Admin Expenses Total | 1,446.80 | 1,588.50 | -8.92% | 3,206.20 | 3.30% |
| Diluted Normalized EPS | 4.66 | 14.77 | -68.45% | 15.53 | -76.50% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.